Original Source(s)
Related Content
FDA Monthly Preview: Key June Decisions to Watch
Several FDA decisions across multiple specialties are expected this month.
May 29, 2026
-
3 min
CDC Updates Cyclosporiasis Surveillance
More than 5,100 additional reports require further analysis as federal and state partners investigate several outbreaks and work to identify their sources.
July 15, 2026
-
3 min
FDA Approves Cefepime-Zidebactam Injection
Phase 3 ENHANCE-1 results showed higher composite clinical cure and microbiologic response rates with cefepime-zidebactam vs meropenem in hospitalized adults with complicated urinary tract infection or acute pyelonephritis.
June 3, 2026
-
2 min
